Different diluents may vary in pH, ionic strength, preservative content, buffering capacity, osmolarity, dissolved gases, and trace impurities
Timing depends on diabetes status, baseline results, other medications, dose changes, kidney risk, gastrointestinal symptoms, and treatment goals
Tirzepatide (Mounjaro/Zepbound) has demonstrated greater weight loss than semaglutide in clinical trials, with participants losing up to 22.5% of body weight
Buyse M, Piedbois P
"I'm all of a sudden, you know, about ready to start taking my medication and I'm like, I now no longer have any confidence in what I have," Bishop says
Clinics should date their regulatory statements and link to the actual FDA action